Wound Management News

Dermatologic surgeons performed more skin reconstructions among the Medicare population than any other single specialist, according to study results.

Sensus Healthcare announced today that it has received FDA clearance to treat keloids caused by surgery or injury with its superficial radiotherapy system.

Sensus Healthcare announced today that it has received FDA clearance to treat keloids caused by surgery or injury with its superficial radiotherapy system.

Prolonged intradermal suture support of excision sites among patients with truncal skin cancer led to significantly decreased scar spread, according to recent study data.

The FDA has designated an investigational treatment for patients with inherited epidermolysis bullosa as breakthrough therapy, Scioderm announced this week.

Patients with hypertrophic cutaneous scars were safely and effectively treated with ablative fractional laser-assisted delivery of triamcinolone acetonide in combination same-session therapy, according to recent study results.

MIAMI BEACH, Fla. — Visits of a dermatologic nature constituted 3.5% of all emergency department traffic during a 1-year period in Alberta, Canada, according to a poster session held at the American Academy of Dermatology Annual Meeting.

Thrombolytic tissue plasminogen activator demonstrated the possibility of being a useful adjunctive treatment for patients with calciphylaxis, according to recent study results.

Tedizolid phosphate was noninferior to linezolid for the treatment of acute bacterial skin and skin structure infections, researchers reported in the Journal of the American Medical Association.

Breast-feeding mothers with Raynaud phenomenon of the nipple demonstrated pain relief with appropriate therapy, and nifedipine was an effective medication for patients who could tolerate it, according to study results.